1. Challenges of developing and validating immunogenicity assays to support comparability studies for biosimilar drug development. (September 2012) Authors: Cai, Xiao-Yan; Thomas, Jeff; Cullen, Constance; Gouty, Dominique Journal: Bioanalysis Issue: Volume 4:Number 17(2012) Page Start: 2169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Challenges of developing and validating immunogenicity assays to support comparability studies for biosimilar drug development. (September 2012) Authors: Cai, Xiao-Yan; Thomas, Jeff; Cullen, Constance; Gouty, Dominique Journal: Bioanalysis Issue: Volume 4:Number 17(2012) Page Start: 2169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa. (19th November 2021) Authors: Yi, B. Alexander; Freedholm, Debra; Widener, Nancy; Wang, Xiaohui; Simard, Emilie; Cullen, Constance; Al‐Saady, Naab M.; Lepor, Norman E.; Coulter, Sara; Lovern, Mark; Bloomfield, Dan Journal: Journal of thrombosis and haemostasis Issue: Volume 20:Number 2(2022) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Recommendations and requirements for the design of bioanalytical testing used in comparability studies for biosimilar drug development. (March 2011) Authors: Cai, Xiao-Yan; Gouty, Dominique; Baughman, Sharon; Ramakrishnan, MS; Cullen, Constance Journal: Bioanalysis Issue: Volume 3:Number 5(2011) Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗